Deferred Tax Assets, Valuation Allowance of Propanc Biopharma, Inc. from 30 Jun 2018 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Propanc Biopharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Jun 2018 to 30 Jun 2025.
  • Propanc Biopharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Jun 2025 was $23,846,119, a 108% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Propanc Biopharma, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $23,846,119 +$12,383,827 +108% 30 Jun 2025 10-K 29 Sep 2025 2025 FY
Q2 2024 $11,462,292 +$306,682 +2.7% 30 Jun 2024 10-K 29 Sep 2025 2025 FY
Q2 2023 $11,155,610 +$861,178 +8.4% 30 Jun 2023 10-K 30 Sep 2024 2024 FY
Q2 2022 $10,294,432 +$339,334 +3.4% 30 Jun 2022 10-K 28 Sep 2023 2023 FY
Q2 2021 $9,955,098 +$1,146,001 +13% 30 Jun 2021 10-K 28 Sep 2022 2022 FY
Q2 2020 $8,809,097 +$1,137,716 +15% 30 Jun 2020 10-K 28 Sep 2021 2021 FY
Q2 2019 $7,671,381 +$1,394,444 +22% 30 Jun 2019 10-K 01 Oct 2020 2020 FY
Q2 2018 $6,276,937 30 Jun 2018 10-K 15 Oct 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.